Literature DB >> 25289525

Ameliorative effect of propolis against cyclophosphamide-induced toxicity in mice.

Sabry A El-Naggar1, Abeer A Alm-Eldeen, Mousa O Germoush, Kamal F El-Boray, Hassan A Elgebaly.   

Abstract

CONTEXT: Cyclophosphamide (CTX) is a common anticancer agent used for the treatment of several malignancies. However, upon treatment, it induces severe toxicity due to its oxidative stress capability. Propolis, a natural product collected by honey bees, has shown several biological activities, such as free radical scavenging and antioxidant agent.
OBJECTIVE: This study elucidates the protective effects of propolis against CTX-induced changes in mice.
MATERIALS AND METHODS: Forty-eight male Swiss albino mice were divided into four groups; group 1 was intraperitoneally (i.p.) injected with 200 µL of phosphate buffer saline (PBS), group 2 was injected with 100 mg/kg/d propolis, group 3 was injected with a single dose of CTX (200 mg/kg), and group 4 was injected with a single dose of CTX (200 mg/kg) followed by propolis (100 mg/kg) for 7 consecutive days. After 12 d, mice were bled and then sacrificed to analyze the hematological, biochemical, and histological parameters.
RESULTS: The results indicated that CTX-injected mice showed an increase in the levels of alanine aminotransferase (ALT), aspartate aminotransferase (AST), urea, and creatinine and a decrease in the total number of white blood cells (WBCs) and platelets. Moreover, dramatically changes in the histological architectures of the liver and kidney were observed. The mice that were injected with CTX/propolis showed an improvement in the levels of ALT, AST, urea, creatinine, WBCs, and platelets. Moreover, the histological picture of the liver and kidney was significantly improved.
CONCLUSIONS: In conclusion, propolis might be considered an effective agent in ameliorating the toxicity resulted from CTX treatment.

Entities:  

Keywords:  Cyclophosphamide; immunosuppression; kidney; liver; propolis; toxicity

Mesh:

Substances:

Year:  2014        PMID: 25289525     DOI: 10.3109/13880209.2014.914230

Source DB:  PubMed          Journal:  Pharm Biol        ISSN: 1388-0209            Impact factor:   3.503


  6 in total

1.  The protective effect of Esculentoside A on experimental acute liver injury in mice.

Authors:  Fang Zhang; Xingtong Wang; Xiaochen Qiu; Junjie Wang; He Fang; Zhihong Wang; Yu Sun; Zhaofan Xia
Journal:  PLoS One       Date:  2014-11-18       Impact factor: 3.240

2.  Protective Effect of Thymoquinone against Cyclophosphamide-Induced Hemorrhagic Cystitis through Inhibiting DNA Damage and Upregulation of Nrf2 Expression.

Authors:  Prashant R Gore; Chaitali P Prajapati; Umesh B Mahajan; Sameer N Goyal; Sateesh Belemkar; Shreesh Ojha; Chandragouda R Patil
Journal:  Int J Biol Sci       Date:  2016-06-07       Impact factor: 6.580

3.  Modulating effects of the synergistic combination of extracts of herbal drugs on cyclophosphamide-induced immunosuppressed mice.

Authors:  Abida Parveen; Sultan Zahiruddin; Nidhi Agarwal; Muhammad Akhtar Siddiqui; Shahid Husain Ansari; Sayeed Ahmad
Journal:  Saudi J Biol Sci       Date:  2021-07-01       Impact factor: 4.219

Review 4.  Potential Protective Effects of Antioxidants against Cyclophosphamide-Induced Nephrotoxicity.

Authors:  Muluken Altaye Ayza; Kaleab Alemayehu Zewdie; Elias Fitsum Yigzaw; Solomon Gashaw Ayele; Bekalu Amare Tesfaye; Gebrehiwot Gebremedhin Tafere; Muzey Gebreyohannes Abrha
Journal:  Int J Nephrol       Date:  2022-04-16

5.  Red propolis reduces inflammation in cyclophosphamide-induced hemorrhagic cystitis in rats.

Authors:  Nayanna De Oliveira Ramos Melo; Hélio De Sousa Peres Júnior; Clara Araujo Diniz; Matheus De Sousa Silva; Telma Leda Gomes de Lemos; Francisco Vagnaldo Fechine Jamacaru; Conceição Aparecida Dornelas
Journal:  Biomedica       Date:  2022-06-01       Impact factor: 1.173

Review 6.  Can propolis and caffeic acid phenethyl ester be promising agents against cyclophosphamide toxicity?

Authors:  Sumeyya Akyol; Mehmet Akif Gulec; Haci Kemal Erdemli; Omer Akyol
Journal:  J Intercult Ethnopharmacol       Date:  2016-01-28
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.